Among other impacts, the committee's closure could hamper efforts to modernize CLIA regulations, which has been a priority among many in the clinical lab space.

From trial phases to personalized care, here’s how healthcare providers can navigate cancer clinical trials and guide ...

Every drug, vaccine and diagnostic test we take has to undergo rigorous clinical testing for safety, quality and ...

This is the first gene editor to use a CRISPR-associated transposase to make targeted edits at therapeutically useful levels ...